All News
EULAR 2024 – Day 3 Report
EULAR treats its attendees to a wonderful lunch each day – Schnitzel, gnocchi, goulash at lunch after muffins and coffee in the morning. It's no wonder the meeting has been a lively one, well attended with a wealth of stimulating ideas, research and discussion. Here are a few of my favorite abstracts and presentations from today, day 3 in Vienna.
Read Article
#EULAR2024 highlights
@Dr_SBattista discusses the beneficial effects of exercise for inflammation and general well-being, presented by Prof Kitas
@RheumNow https://t.co/WAHg4ub8R3
Mrinalini Dey DrMiniDey ( View Tweet)
PARE summary at #EULAR2024 - love the word cloud highlighting the posters @RheumNow
RA, SLE and JIA were the key RMDs that were focused on. By Silvia Aguleria https://t.co/WbSKwE6vXs
Links:
Bella Mehta bella_mehta ( View Tweet)
EULAR PARE highlights
- Need close collaboration between patients and physicians.
-Child to adult transition need to be smooth to be successful (30% patients can be lost in transitions)
- We need patients to participate in Health Technology Assessment
@rheumnow #EULAR2024 https://t.co/50qFpRGXo2
Links:
Bella Mehta bella_mehta ( View Tweet)
CAR-T - autologous vs allogenic , need for full induction , safety of retreatment, CAR-T lymphoma/leukaemia, cost, ideal candidate ? @RheumNow #EULAR2024
Peter Nash drpnash ( View Tweet)
FINDINGS ON MRI OF THE SACROILIAC JOINTS 7 YEARS AFTER PREGNANCY IN WOMEN WITH AND WITHOUT POSTPARTUM BUTTOCK/PELVIC PAIN - source of misdiagnosis but not a cause of progressive lesions @RheumNow #EULAR2024 https://t.co/aEvlkMZtQw
Peter Nash drpnash ( View Tweet)
Some of the great questions in ICI-induced irAE pathophysiology, from the great Andy Cope @KingsCollegeLon
#EULAR2024 @RheumNow https://t.co/aHDqnvhboo
David Liew drdavidliew ( View Tweet)
#Scleroderma updated #EULAR2024
#recommendations @eular_org
SKIN
Are they good enough?
Great work by task force @EUSTAR_org
Do we alter initial Rx if v high mRSS?
Ex #MMF not much improvement on skin vs #RTX #Cyclo
Or combo Rx?
We need to improve #SoC
?CAR-T ? RCT
@RheumNow https://t.co/WhEzDdjVeu
Janet Pope Janetbirdope ( View Tweet)
New reccs for knee/hip #OA w/2 overarching principles
1. Biopsychosocial approach
2.Individualized Rx w/shared decision making (includes education, diet/exercise, healthy weight, appropriate assistive device/footware, modify work factors, pain coping skills)
#EULAR24
@rheumnow https://t.co/0LVLBMGO7L
TheDaoIndex KDAO2011 ( View Tweet)
Thanks for these updates recommendations for hip/knee OA -- but, still not much has changed. #eular2034 https://t.co/NMwFWxwocF
Dr. John Cush RheumNow ( View Tweet)
AI meets Rheumatology: ChatGPT and patient response optimization
Large language models like ChatGPT, trained on vast text data, are revolutionizing healthcare by understanding and generating human-like language.
https://t.co/GzT9UvndTX https://t.co/ziOh8oCbZ9
Dr. John Cush RheumNow ( View Tweet)
@RheumNow The always erudite @LCalabreseDO is no slouch of a debating opponent, however. He acknowledges that the science has been imperfect, too much is wrapped up in it, and that fibromyalgia can teach a lot to long COVID. #EULAR2024 @RheumNow https://t.co/TzR4SMZh9f
Links:
David Liew drdavidliew ( View Tweet)
@RheumNow @LCalabreseDO @NIH and Len gives us some key recommendations for better practice for long COVID - for me, equally as applicable to fibromyalgia as to long COVID.
Fantastic discussion #EULAR2024 @RheumNow https://t.co/8PnjPEKcOu
David Liew drdavidliew ( View Tweet)
#IgG4 Pearls
Thanks for sharing
Isolated ⬆️ serum #IgG4 level
✅ How high? 5x ULN ➡️ PPV 75%
✅Typical organ(s) involved?
❓Another explanation
Dr Jone Stone
#Rheumatology #EULAR2024 https://t.co/UVKmH57iVM https://t.co/uxHBl0I3cM
Links:
Ask The Rheumatologist LastManStand85 ( View Tweet)
EULAR guidelines for screening for TB in rheumatic disease patients
#EULAR2024 https://t.co/jaixl8lGkY
Jilaine Bolek Berquist BolekBerqui ( View Tweet)
DMOADs in #osteoarthritis at #EULAR2024: 1) Tonia Vincent: StepUp OA endotype SF proteomics —> endothelial to mesenchymal transition proteins. 2) Phil Conaghan: proregenerative (& degeneration slowing) therapies in pipeline. 3) @Larhumato: novel RCT designs & structure outcomes
Tuhina Neogi, MD, PhD Tuhina_Neogi ( View Tweet)
Recommendation for management of fatigue in people with rheumatic disease.
Considering fatigue as a surrogate for inflammation and changing medication accordingly is part of it.
I will also add yearly blood work including:
1- VitD
2-HBA1c and LDl
3-TsH. https://t.co/3QvPqMxZSN
Links:
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
When would I use
#Aclasta vs #Prolia since #denosumab has LESS #fractures
▶️younger women with #osteoporosis requiring Rx due to long safety
▶️less wearing off when stopping it
▶️noncompliant Pts as prolia reverses effect when dose is missed
@RheumNow #EULAR2024 @eular_org https://t.co/0RTGx0sCTd
Janet Pope Janetbirdope ( View Tweet)
If your GCA flares, do you get the same features as you did at diagnosis?
20% of the time it can be new, so keep on doing the checklist!
(also, visual flares uncommon - the power of pred)
#EULAR2024 POS0110 @MayoClinic @MdWarrington @RheumNow https://t.co/hkF8vJT6HI
Links:
David Liew drdavidliew ( View Tweet)
What is better for #Rx of
#osteoporosis?
#Denosumab or ##Zoledronic acid?
#Prolia compared to #Aclasta
Giant admin US data of 125,000 Rx niaive women with #OP
▶️Prolia has LESS fractures!
POS0583 #EULAR2024 @eular_org @RheumNow https://t.co/eo1ny2VIRf
Links:
Janet Pope Janetbirdope ( View Tweet)
